IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas.
IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas.
复制标题
DOI:
10.1002/ijc.24623
复制
发表时间:
2009-12-01
影响因子:
6.4
通讯作者:
Gammon, Marilie D.
中科院分区:
文献类型:
--
作者:
Hoyo, Cathrine;Schildkraut, Joellen M.;Murphy, Susan K.;Chow, Wong-Ho;Vaughan, Thomas L.;Risch, Harvey;Marks, Jeffrey R.;Jirtle, Randy L.;Calingeart, Brian;Mayne, Susan;Fraumeni, Joseph, Jr.;Gammon, Marilie D.
The mannose 6 phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) encodes a protein that plays a critical role in tumor suppression, in part by modulating bioavailability of a potent mitogen, insulin-like growth factor-2 (IGF2). We tested the hypothesis that the common non-synonymous genetic variants in M6P/IGF2R c.901C>G (Leu>Val) in exon 6 and c.5002G>A (Gly>Arg) in exon 34 are associated with risk of esophageal and gastric cancers. Study participants in this population-based study comprise 197 controls and 182 cases, including 105 with esophageal-gastric cardia adenocarcinoma (EGA), 57 with non-cardia gastric adenocarcinoma and 20 with esophageal squamous cell carcinoma (ES). Among white males, odds ratios (ORs) were elevated in relation to carrying at least one c.901C>G allele for EGA (OR= 1.9; 95%CI=1.0–3.6) and non-cardia gastric cancer (OR=2.5; 95%CI=1.2–5.5), but not ES. Exploratory subgroup analyses suggested that associations between EGA and this variant were stronger among irregular or non-users of non-steroidal anti-inflammatory drugs (NSAIDs) (OR=2.3; 95%CI=1.2–4.2) and cigarette smokers (OR=2.1; 95%CI=1.0–4.2). An association between carrying the c.5002G>A genotype and EGA was not evident. These findings suggest that non-synonymous polymorphisms in M6P/IGF2R may contribute to the risks of EGA and non-cardia adenocarcinomas. Larger studies are required to confirm these findings.
登录
查看更多内容
影响因子:
3.8
作者:
Kaku, K.;Osada, H.;Sekiya, S.
通讯作者:
Sekiya, S.
影响因子:
4.8
作者:
Schaffer, BS;Lin, MF;MacDonald, RG
通讯作者:
MacDonald, RG
影响因子:
120.7
作者:
Mokdad, AH;Ford, ES;Marks, JS
通讯作者:
Marks, JS
影响因子:
10.3
作者:
Gammon, MD;Schoenberg, JB;Fraumeni, JF
通讯作者:
Fraumeni, JF
影响因子:
8.4
作者:
Ryan, Aoife M.;Rowley, Suzanne P.;Reynolds, John V.
通讯作者:
Reynolds, John V.